EXPANDED ACCESS PROGRAMS

For people experiencing treatment failure who have limited treatment options, expanded access programs (EAPs) offer the chance to add investigational medications to their regimens even though those medications are still awaiting final FDA approval.

Click here to learn why expanded access programs are an important way to keep people living with HIV healthy and why EAPs are an important component of CRI’s mission to lead the way in HIV/AIDS research and to ensure access to life-saving drugs to those in need.

CRI currently does not have any open and enrolling expanded access programs.

For more information on EAPs, please call the Boston Research Team at 617.502.1702 or the Springfield Research Team at 413.734.2264.